Clinical Trials Directory

Trials / Completed

CompletedNCT05127733

Online Cognitive Behavioural Therapy for Substance Use Disorder: The Impact of Peer Support

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
198 (actual)
Sponsor
Centre for Addiction and Mental Health · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the efficacy and cost-effectiveness of Breaking Free Online, in a comparison of outpatients seeking treatment for substance use disorder who receive standard care with group peer support, versus with access to Breaking Free Online, versus with access to Breaking Free Online and individual peer support.

Detailed description

A total of 225 outpatients receiving standard care for substance use disorder from the Centre for Addiction and Mental Health will be randomized to receive clinical monitoring (CM) with group peer support, Breaking Free Online only, or Breaking Free Online with individual peer support, in an eight-week trial with a six-month follow-up period. The primary outcome is substance use frequency; secondary outcomes include substance use problems, depression, anxiety, quality of life, treatment engagement, and cost-effectiveness.

Conditions

Interventions

TypeNameDescription
BEHAVIORALOnline Cognitive Behavioural TherapyInteractive program utilizing cognitive behavioural therapy principles that guides users through its components and provides feedback, which facilitates behavior change (i.e., reduction in alcohol or substance use).
BEHAVIORALIndividual Peer SupportWeekly meetings with a trained peer support worker who guides participants through the BFO platform, reviews the platform's content with them, and supports them in the creation of an action strategy based on the platform's suggestions.
BEHAVIORALGroup Peer SupportMeetings with a group of peers led by a trained peer support worker/volunteer which will offer the participants an opportunity to discuss their experiences in a supportive and open environment.

Timeline

Start date
2021-10-25
Primary completion
2025-12-19
Completion
2025-12-19
First posted
2021-11-19
Last updated
2026-03-27

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT05127733. Inclusion in this directory is not an endorsement.